HB 1664-FN (2024): relative to legal remedies for individuals who receive medical detransitioning.
Cite this page
Granite Record indexes the General Court’s record; it is not that record. Where a citation allows only one source, cite the General Court — every page here links to what it is drawn from. The date below is the day the page was read.
- MLA
- “HB 1664-FN (2024): relative to legal remedies for individuals who receive medical detransitioning.” Granite Record, https://graniterecord.org/bill/2024/hb1664. Accessed 24 Oct. 2026.
- APA
- Granite Record. (n.d.). HB 1664-FN (2024): relative to legal remedies for individuals who receive medical detransitioning. Retrieved 24 Oct. 2026, from https://graniterecord.org/bill/2024/hb1664
- Chicago
- Granite Record. “HB 1664-FN (2024): relative to legal remedies for individuals who receive medical detransitioning.” Accessed 24 Oct. 2026. https://graniterecord.org/bill/2024/hb1664.
- BibTeX
@misc{bill-2024-hb1664, title = {HB 1664-FN (2024): relative to legal remedies for individuals who receive medical detransitioning.}, howpublished = {Granite Record}, url = {https://graniterecord.org/bill/2024/hb1664}, note = {Accessed 24 Oct. 2026} }
HB 1664-FN (2024)
relative to legal remedies for individuals who receive medical detransitioning.
- Status: Indefinitely postponed
- Term: 2023-2024
- House committee: Judiciary
- Subject: Discrimination
The Story
It was introduced on January 3, 2024 and referred to the House Judiciary committee. The committee held a public hearing on February 21, 2024, with 234 people signed in online: 75 in support and 159 in opposition. The committee met in executive session on March 6, 2024 to vote on its recommendation. The majority recommended that the House kill it, and the minority recommended that the House pass it with changes (amendment 2024-0972h), by a vote of 12–8. The report was placed on the regular calendar. On March 21, 2024 the House voted to kill it and bar the subject for the rest of the term on a roll call 181–164, on a motion by Rep. Lucy Weber.
Sponsors
- Rep. J.R. Hoell (R - Merr 27) (prime sponsor)
- Rep. Alicia Lekas (R - Hills 38)
- Rep. Mike Drago (R - Rock 4)
- Rep. Jim Kofalt (R - Hills 32)
- Rep. Kelley Potenza (R - Straf 19)
- Rep. Michael Granger (R - Straf 2)
- Rep. Mike Belcher (R - Carr 4)
- Rep. Diane Kelley (R - Hills 32)
- Rep. Larry Gagne (R - Hills 16)
- Sen. Ruth Ward (R - SD8)
- Sen. Keith Murphy (R - SD16)
Hearings and Sessions
- February 21, 2024, 9:00 AM: public hearing, House Judiciary, LOB 206-208
- March 6, 2024, 10:00 AM: executive session, House Judiciary, LOB 206-208
Votes
- March 21, 2024, House: Indefinitely Postpone — yeas 181, nays 164, passed
The Docket
- January 3, 2024: Introduced 01/03/2024 and referred to Judiciary
- February 21, 2024: Public Hearing: 02/21/2024 09:00 am LOB 206-208
- March 6, 2024: Executive Session: 03/06/2024 10:00 am LOB 206-208
- March 6, 2024: Majority Committee Report: Inexpedient to Legislate 03/06/2024 (Vote 12-8; RC)
- March 12, 2024: Minority Committee Report: Ought to Pass with Amendment #2024-0972h
- March 21, 2024: Indefinitely Postpone (Rep. Weber): MA RC 181-164 03/21/2024
Laws It Would Change
Related Bills
- SB 304-FN (2024): creating a cause of action for medical injuries resulting from the administration or prescription of gender transition surgery, cross-sex hormones, or puberty-blocking drugs and providing protections for individuals who receive medical detransitioning.